AQR Capital Management’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$948K Buy
846,233
+261,208
+45% +$293K ﹤0.01% 2235
2025
Q1
$462K Buy
585,025
+437,423
+296% +$346K ﹤0.01% 2472
2024
Q4
$244K Buy
147,602
+123,518
+513% +$204K ﹤0.01% 2589
2024
Q3
$84.3K Buy
24,084
+7,624
+46% +$26.7K ﹤0.01% 2668
2024
Q2
$54K Sell
16,460
-5,638
-26% -$18.5K ﹤0.01% 2536
2024
Q1
$162K Sell
22,098
-212,960
-91% -$1.56M ﹤0.01% 2286
2023
Q4
$879K Sell
235,058
-97,853
-29% -$366K ﹤0.01% 1650
2023
Q3
$706K Buy
+332,911
New +$706K ﹤0.01% 1728
2023
Q2
Sell
-271,399
Closed -$1.55M 2215
2023
Q1
$1.55M Buy
+271,399
New +$1.55M ﹤0.01% 1359
2022
Q2
Sell
-15,438
Closed -$599K 2216
2022
Q1
$599K Sell
15,438
-11,393
-42% -$442K ﹤0.01% 1749
2021
Q4
$1.57M Sell
26,831
-9,301
-26% -$544K ﹤0.01% 1323
2021
Q3
$2.14M Sell
36,132
-1,992
-5% -$118K ﹤0.01% 1101
2021
Q2
$3.31M Buy
38,124
+4,277
+13% +$371K 0.01% 969
2021
Q1
$2.79M Sell
33,847
-1,475
-4% -$122K ﹤0.01% 1034
2020
Q4
$3.21M Sell
35,322
-5,184
-13% -$471K 0.01% 942
2020
Q3
$1.62M Sell
40,506
-8,979
-18% -$359K ﹤0.01% 1201
2020
Q2
$1.7M Sell
49,485
-2,994
-6% -$103K ﹤0.01% 1228
2020
Q1
$1.17M Buy
52,479
+33,393
+175% +$742K ﹤0.01% 1268
2019
Q4
$374K Sell
19,086
-10,493
-35% -$206K ﹤0.01% 1854
2019
Q3
$459K Sell
29,579
-403
-1% -$6.25K ﹤0.01% 1779
2019
Q2
$609K Sell
29,982
-3,790
-11% -$77K ﹤0.01% 1665
2019
Q1
$593K Sell
33,772
-5,042
-13% -$88.5K ﹤0.01% 1741
2018
Q4
$498K Sell
38,814
-8,393
-18% -$108K ﹤0.01% 1781
2018
Q3
$769K Hold
47,207
﹤0.01% 1803
2018
Q2
$535K Buy
47,207
+15,170
+47% +$172K ﹤0.01% 1957
2018
Q1
$313K Buy
+32,037
New +$313K ﹤0.01% 2038